Comment on "Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment"

Affiliations

¹ Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
² Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
³ Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Comment

Qi-Chen Chen et al. Ann Surg. 2021.

. 2021 Dec 1;274(6):e758-e759.

doi: 10.1097/SLA.0000000000004262.

¹ Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
² Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina, USA.
³ Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment.
Lewis A, Raoof M, Ituarte PHG, Williams J, Melstrom L, Li D, Lee B, Singh G. Lewis A, et al. Ann Surg. 2019 Dec;270(6):1131-1137. doi: 10.1097/SLA.0000000000002809. Ann Surg. 2019. PMID: 29746336

1. Lewis A, Raoof M, Ituarte PHG, et al. Resection of the primary gastrointestinal neuroendocrine tumor improves survival with or without liver treatment. Ann Surg 2019; 270:1131–1137.
1. O’Toole D, Kianmanesh R, Caplin M. ENETS 2016 consensus guidelines for the management of patients with digestive neuroendocrine tumours: an update. Neuroendocrinology 2016; 103:117–118.
1. Howe JR, Cardona K, Fraker DL, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society. Pancreas 2017; 46:715–731.
1. Ahmed A, Turner G, King B, et al. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer 2009; 16:885–894.
1. Huttner FJ, Schneider L, Tarantino I, et al. Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population- based, propensity score-matched survival analysis. Langenbecks Arch Surg 2015; 400:715–723.